VISUGROMAB

UNII:	NX3NW9MM9W
Formula:
Preferred Substance Name:	VISUGROMAB
GSRS Full Record:	NX3NW9MM9W i

2556646-63-8
CTL002
CTL-002
GAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV2-5*02 (92.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (10.7.10) (26-35.53-59.98-107)) (1-118)-HOMO SAPIENS IGHG4*01, G4V5 H P10 (CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 (229-338), CH3 (339-443), CHS K2>DEL (444)) (119-444)), (132-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV6-15*01 (82.1%) -IGKJ2*01 (100%)/HOMO SAPIENS IGKV1-9*01 (76.8%) -IGKJ2*01 (91.7%) Q120>G (100), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA
IMMUNOGLOBULIN G4 (226-PROLINE,DE-445-LYSINE), ANTI-(HUMAN GROWTH DIFFERENTIATION FACTOR 15) (HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS GDF15 (GROWTH DIFFERENTIATION FACTOR 15, PLAB, MIC-1, PDF, MIC1, NAG-1, PTGFB)), MONOCLONAL ANTIBODY
VISUGROMAB [INN]
VISUGROMAB [USAN]
VISUGROMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VISUGROMAB

Synonyms and Mappings

Resources